JNJ-38877618

Overview

JNJ-38877618 is a potent, highly selective, orally bioavailable Met kinase inhibitor with IC 50 s of 2 and 3 nM for wild type and mutant Met, respectively.

Application

Products | Products > Disease Areas > Gastric Cancer | Products > Disease Areas > Liver Cancer | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > c-Met/HGFR

Product Information

• Catalog No.: HY-111050
• CAS No.: 943540-74-7
• Molecular Formula: C20H12F2N6
• Molecular Weight: 374.35
• Purity: 98.85%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 0.5 mg/mL (1.34 mM); Clear solution
• Availability: In-stock

Source

Original product source